Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Insurers Remain Skeptical Of Public Plan As Sen. Schumer Rolls Out Proposal

Executive Summary

Representatives of the insurance industry and big business remained skeptical about the feasibility and fairness of a public insurance option competing with private plans during a Senate Finance Committee roundtable discussion May 5
Advertisement

Related Content

Pharma Cost-Saving Options Take Backseat In Senate Reform Roundtable
Pharma Cost-Saving Options Take Backseat In Senate Reform Roundtable
Pharma Share Of Health Reform Cost Savings To Come From Drug Access, Compliance, Personalized Medicine
Health Reform Public Plan Will Protect Level Playing Field For Insurers, Sebelius Asserts
Public Health Plan Must Be Part Of House Reform Bill, Rep. Waxman Says
Senate Options Include Barring CER’s “Fast Track” To Coverage
Public Plan Using Medicare Rates Would Face Major Push-Back, Insurers Say

Topics

Advertisement
UsernamePublicRestriction

Register

PS051044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel